Evaluation of RAD51C as cancer susceptibility gene in a large breast-ovarian cancer patient population referred for genetic testing

K. De Leeneer, M. Van Bockstal, S. De Brouwer, N. Swietek, P. Schietecatte, N. Sabbaghian, J. Van den Ende, S. Willocx, K. Storm, B. Blaumeiser, C. J. Van Asperen, J. T. Wijnen, K. Leunen, E. Legius, G. Michils, G. Matthijs, M. J. Blok, E. Gomez-Garcia, A. De Paepe, M. TischkowitzB. Poppe, K. Claes*

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

16 Citations (Web of Science)
Original languageEnglish
Pages (from-to)393-398
JournalBreast Cancer Research and Treatment
Issue number1
Publication statusPublished - May 2012


  • Hereditary breast and ovarian cancer
  • RAD51C
  • Germline mutations
  • BRCA1/2-negative

Cite this